143 related articles for article (PubMed ID: 38777670)
1. TNIK's emerging role in cancer, metabolism, and age-related diseases.
Ewald CY; Pulous FE; Lok SWY; Pun FW; Aliper A; Ren F; Zhavoronkov A
Trends Pharmacol Sci; 2024 Jun; 45(6):478-489. PubMed ID: 38777670
[TBL] [Abstract][Full Text] [Related]
2. The essential role of TNIK gene amplification in gastric cancer growth.
Yu DH; Zhang X; Wang H; Zhang L; Chen H; Hu M; Dong Z; Zhu G; Qian Z; Fan J; Su X; Xu Y; Zheng L; Dong H; Yin X; Ji Q; Ji J
Oncogenesis; 2014 Feb; 2(2):e89. PubMed ID: 24566388
[TBL] [Abstract][Full Text] [Related]
3. The germinal center kinase TNIK is required for canonical NF-κB and JNK signaling in B-cells by the EBV oncoprotein LMP1 and the CD40 receptor.
Shkoda A; Town JA; Griese J; Romio M; Sarioglu H; Knöfel T; Giehler F; Kieser A
PLoS Biol; 2012; 10(8):e1001376. PubMed ID: 22904686
[TBL] [Abstract][Full Text] [Related]
4. Traf2- and Nck-interacting kinase (TNIK) is involved in the anti-cancer mechanism of dovitinib in human multiple myeloma IM-9 cells.
Chon HJ; Lee Y; Bae KJ; Byun BJ; Kim SA; Kim J
Amino Acids; 2016 Jul; 48(7):1591-9. PubMed ID: 26995282
[TBL] [Abstract][Full Text] [Related]
5. Direct conversion of osteosarcoma to adipocytes by targeting TNIK.
Hirozane T; Masuda M; Sugano T; Sekita T; Goto N; Aoyama T; Sakagami T; Uno Y; Moriyama H; Sawa M; Asano N; Nakamura M; Matsumoto M; Nakayama R; Kondo T; Kawai A; Kobayashi E; Yamada T
JCI Insight; 2021 Feb; 6(3):. PubMed ID: 33400690
[TBL] [Abstract][Full Text] [Related]
6. A novel aminothiazole KY-05009 with potential to inhibit Traf2- and Nck-interacting kinase (TNIK) attenuates TGF-β1-mediated epithelial-to-mesenchymal transition in human lung adenocarcinoma A549 cells.
Kim J; Moon SH; Kim BT; Chae CH; Lee JY; Kim SH
PLoS One; 2014; 9(10):e110180. PubMed ID: 25337707
[TBL] [Abstract][Full Text] [Related]
7. Structural Insight into TNIK Inhibition.
Kukimoto-Niino M; Shirouzu M; Yamada T
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361804
[TBL] [Abstract][Full Text] [Related]
8. Traf2- and Nck-interacting kinase is essential for Wnt signaling and colorectal cancer growth.
Shitashige M; Satow R; Jigami T; Aoki K; Honda K; Shibata T; Ono M; Hirohashi S; Yamada T
Cancer Res; 2010 Jun; 70(12):5024-33. PubMed ID: 20530691
[TBL] [Abstract][Full Text] [Related]
9. Jatrorrhizine inhibits mammary carcinoma cells by targeting TNIK mediated Wnt/β-catenin signalling and epithelial-mesenchymal transition (EMT).
Sun Y; Gao X; Wu P; Wink M; Li J; Dian L; Liang Z
Phytomedicine; 2019 Oct; 63():153015. PubMed ID: 31302315
[TBL] [Abstract][Full Text] [Related]
10. Nuclear expression of phosphorylated TRAF2- and NCK-interacting kinase in hepatocellular carcinoma is associated with poor prognosis.
Jin J; Jung HY; Wang Y; Xie J; Yeom YI; Jang JJ; Lee KB
Pathol Res Pract; 2014 Oct; 210(10):621-7. PubMed ID: 25160513
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic targets in the Wnt signaling pathway: Feasibility of targeting TNIK in colorectal cancer.
Masuda M; Sawa M; Yamada T
Pharmacol Ther; 2015 Dec; 156():1-9. PubMed ID: 26542362
[TBL] [Abstract][Full Text] [Related]
12. Fbxo3-Dependent Fbxl2 Ubiquitination Mediates Neuropathic Allodynia through the TRAF2/TNIK/GluR1 Cascade.
Lin TB; Hsieh MC; Lai CY; Cheng JK; Chau YP; Ruan T; Chen GD; Peng HY
J Neurosci; 2015 Dec; 35(50):16545-60. PubMed ID: 26674878
[TBL] [Abstract][Full Text] [Related]
13. Synergistic inhibition effect of TNIK inhibitor KY-05009 and receptor tyrosine kinase inhibitor dovitinib on IL-6-induced proliferation and Wnt signaling pathway in human multiple myeloma cells.
Lee Y; Jung JI; Park KY; Kim SA; Kim J
Oncotarget; 2017 Jun; 8(25):41091-41101. PubMed ID: 28467797
[TBL] [Abstract][Full Text] [Related]
14. Emergence of TNIK inhibitors in cancer therapeutics.
Yamada T; Masuda M
Cancer Sci; 2017 May; 108(5):818-823. PubMed ID: 28208209
[TBL] [Abstract][Full Text] [Related]
15. Discovery of 4-phenyl-2-phenylaminopyridine based TNIK inhibitors.
Ho KK; Parnell KM; Yuan Y; Xu Y; Kultgen SG; Hamblin S; Hendrickson TF; Luo B; Foulks JM; McCullar MV; Kanner SB
Bioorg Med Chem Lett; 2013 Jan; 23(2):569-73. PubMed ID: 23232060
[TBL] [Abstract][Full Text] [Related]
16. Discovery of 3,4-Dihydrobenzo[
Li Y; Zhang L; Yang R; Qiao Z; Wu M; Huang C; Tian C; Luo X; Yang W; Zhang Y; Li L; Yang S
J Med Chem; 2022 Feb; 65(3):1786-1807. PubMed ID: 34985886
[TBL] [Abstract][Full Text] [Related]
17. The Traf2- and Nck-interacting kinase as a putative effector of Rap2 to regulate actin cytoskeleton.
Taira K; Umikawa M; Takei K; Myagmar BE; Shinzato M; Machida N; Uezato H; Nonaka S; Kariya K
J Biol Chem; 2004 Nov; 279(47):49488-96. PubMed ID: 15342639
[TBL] [Abstract][Full Text] [Related]
18. Discovery of benzo[d]oxazol-2(3H)-one derivatives as a new class of TNIK inhibitors for the treatment of colorectal cancer.
Luo X; Yang R; Li Y; Zhang L; Yang S; Li L
Bioorg Med Chem Lett; 2022 Jul; 67():128745. PubMed ID: 35447345
[TBL] [Abstract][Full Text] [Related]
19. TNIK is a conserved regulator of glucose and lipid metabolism in obesity.
Pham TCP; Dollet L; Ali MS; Raun SH; Møller LLV; Jafari A; Ditzel N; Andersen NR; Fritzen AM; Gerhart-Hines Z; Kiens B; Suomalainen A; Simpson SJ; Salling Olsen M; Kieser A; Schjerling P; Nieminen AI; Richter EA; Havula E; Sylow L
Sci Adv; 2023 Aug; 9(32):eadf7119. PubMed ID: 37556547
[TBL] [Abstract][Full Text] [Related]
20. MINK and TNIK differentially act on Rap2-mediated signal transduction to regulate neuronal structure and AMPA receptor function.
Hussain NK; Hsin H; Huganir RL; Sheng M
J Neurosci; 2010 Nov; 30(44):14786-94. PubMed ID: 21048137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
